JPH09506090A - プロリル・エンドペプチダーゼ阻害剤 - Google Patents

プロリル・エンドペプチダーゼ阻害剤

Info

Publication number
JPH09506090A
JPH09506090A JP7515618A JP51561895A JPH09506090A JP H09506090 A JPH09506090 A JP H09506090A JP 7515618 A JP7515618 A JP 7515618A JP 51561895 A JP51561895 A JP 51561895A JP H09506090 A JPH09506090 A JP H09506090A
Authority
JP
Japan
Prior art keywords
compound
reaction
acid
mmol
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP7515618A
Other languages
English (en)
Japanese (ja)
Inventor
ピート，ノートン，ピー．
バークハート，ジヨゼフ，ピー．
メーディ，シュジャース
Original Assignee
メレルファーマスーティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メレルファーマスーティカルズ インコーポレイテッド filed Critical メレルファーマスーティカルズ インコーポレイテッド
Publication of JPH09506090A publication Critical patent/JPH09506090A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP7515618A 1993-12-02 1994-11-08 プロリル・エンドペプチダーゼ阻害剤 Ceased JPH09506090A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16110693A 1993-12-02 1993-12-02
US08/161,106 1993-12-02
PCT/US1994/012865 WO1995015310A1 (en) 1993-12-02 1994-11-08 Prolyl endopeptidase inhibitors

Publications (1)

Publication Number Publication Date
JPH09506090A true JPH09506090A (ja) 1997-06-17

Family

ID=22579844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7515618A Ceased JPH09506090A (ja) 1993-12-02 1994-11-08 プロリル・エンドペプチダーゼ阻害剤

Country Status (19)

Country Link
US (1) US5661167A (enExample)
EP (1) EP0731788B1 (enExample)
JP (1) JPH09506090A (enExample)
KR (1) KR100341982B1 (enExample)
CN (1) CN1136806A (enExample)
AT (1) ATE223894T1 (enExample)
AU (1) AU684861B2 (enExample)
CA (1) CA2177821C (enExample)
DE (1) DE69431359T2 (enExample)
DK (1) DK0731788T3 (enExample)
ES (1) ES2179093T3 (enExample)
HU (1) HUT74687A (enExample)
IL (1) IL111775A (enExample)
NO (1) NO962238D0 (enExample)
NZ (1) NZ276600A (enExample)
PT (1) PT731788E (enExample)
TW (1) TW280818B (enExample)
WO (1) WO1995015310A1 (enExample)
ZA (1) ZA949302B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
JP4806628B2 (ja) 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
EP1824846A2 (en) 2003-11-03 2007-08-29 Probiodrug AG Novel compounds for the treatment of neurological disorders
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
WO2008144748A1 (en) * 2007-05-21 2008-11-27 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CA2938369C (en) 2014-01-28 2019-08-06 Spirit Global Energy Solutions, Inc. Down-hole gas and solids separator utilized in production hydrocarbons
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
WO1990012005A1 (fr) * 1989-04-13 1990-10-18 Japan Tobacco Inc. Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase

Also Published As

Publication number Publication date
US5661167A (en) 1997-08-26
EP0731788B1 (en) 2002-09-11
DK0731788T3 (da) 2003-01-20
IL111775A0 (en) 1995-01-24
ATE223894T1 (de) 2002-09-15
NZ276600A (en) 1997-09-22
AU1091795A (en) 1995-06-19
CA2177821C (en) 2000-03-28
DE69431359T2 (de) 2003-07-31
PT731788E (pt) 2003-01-31
HUT74687A (en) 1997-01-28
CA2177821A1 (en) 1995-06-08
KR100341982B1 (ko) 2002-11-30
ES2179093T3 (es) 2003-01-16
EP0731788A1 (en) 1996-09-18
DE69431359D1 (de) 2002-10-17
WO1995015310A1 (en) 1995-06-08
IL111775A (en) 1998-06-15
HU9601472D0 (en) 1996-07-29
AU684861B2 (en) 1998-01-08
NO962238L (no) 1996-05-31
NO962238D0 (no) 1996-05-31
CN1136806A (zh) 1996-11-27
TW280818B (enExample) 1996-07-11
ZA949302B (en) 1995-08-07

Similar Documents

Publication Publication Date Title
US4692458A (en) Anti-hypertensive agents
US5496927A (en) Peptidase inhibitors
KR900008004B1 (ko) 펩티다제 억제물의 제조방법
AU684861B2 (en) Prolyl endopeptidase inhibitors
JP2005523248A (ja) ジペプチジルペプチダーゼｉｖの阻害剤
US20040142876A1 (en) Peptides and their use as inhibitors of hepatitis c virus ns3 protease
US4745124A (en) Orally effective anti-hypertensive agents
JPH08259593A (ja) カルボキシアルキル ペプチド誘導体
MC2221A1 (fr) Derives d'acide acetique
CZ290104B6 (cs) Peptidový derivát, způsob jeho přípravy a použitía farmaceutický přípravek s jeho obsahem
US4912120A (en) 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
JPH10501529A (ja) エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
JPH07507069A (ja) ヒトの心臓キマーゼを含むアンギオテンシンｉキマーゼに関する阻害剤
HU201032B (en) Process for production of izoxasoles hindering transglumatinase and medical compositions containing them
US4929630A (en) Transglutaminase inhibitors
FR2459236A1 (fr) Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques notamment comme analgesiques
JPH10509727A (ja) Ｎ−末端スルホニル−又はアミノスルホニル基を有する新規のジペプチドのｐ−アミノベンジルアミド
JPH10500992A (ja) 新しいエラスターゼ阻害剤
US4734420A (en) Anti-hypertensive agents
US6265381B1 (en) Orally-active elastase inhibitors
US4690936A (en) Anti-hypertensive agents
US4833152A (en) Anti-hypertensive agents
CH653017A5 (fr) Derives s-acyles d'acides mercaptoacylamines ayant une activite inhibitrice de l'enzyme de conversion de l'angiotensine.
KR19990071822A (ko) α-케토에스테르 및 α-케토아미드의 아실화된 에놀 유도체
US5389612A (en) Phosphonic peptide inhibitors of bacterial collagenases

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040601

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040901

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20041018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041130

RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20050401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060523

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20061010

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061121